Tue, Jul 29, 2014, 11:09 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

MiMedx Group, Inc. Message Board

jpdgrisgris 2 posts  |  Last Activity: May 6, 2014 11:30 AM Member since: Sep 14, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • jpdgrisgris by jpdgrisgris May 6, 2014 11:30 AM Flag

    The large-cap med tech stocks are now trading at an average NTM.

    Sentiment: Buy

  • jpdgrisgris by jpdgrisgris May 6, 2014 11:26 AM Flag

    This information is interesting if not determinative...

    Medical Technologies & Diagnostics - Please click here for the full report with disclaimers
    Thoughts on the Small-Cap Growth Med Tech Correction
    Industry Update
    Small-Cap Growth Med Tech Stock Performance
    REPORT HIGHLIGHTS: We believe that the correction in small-cap growth med tech stocks is probably over since the stocks have declined by an average of 17.4% vs. a 0.5% decline in the S&P 600 since 2/18/14 and the stocks are now trading at a premium to their five-year average multiple that is similar to other med tech stocks. We think the sell-off has created attractive entry points for small-cap growth names we cover including Strong-Buy rated CSII and WMGI and Buy-rated AMDA, GNMK, and SPNC.
    Over the past six weeks, the small-cap growth med stocks have declined sharply. Since 2/18/14, the stocks in our small-cap growth med tech group (see our comp tables on starting on page 3) declined by an average of 17.4%. This compares with a 0.5% decline in the S&P 600 index and a 3.2% decline in the NASDAQ Composite index during the same period. We believe that the decline was driven by a rotation away from higher-growth, higher-multiple (i.e. "momentum") stocks.
    The small-cap growth med tech stocks are now trading at a 19% premium to their five-year average next-twelve-month (NTM) EV/Sales. The decline in the stocks has resulted in multiple compression. Small-cap growth med tech stocks' average NTM EV/S multiple has fallen by 25% from 6.1x on 2/18/14 to 4.6x currently. At the current average NTM EV/S of 4.6x, the group is now at a 19% premium to its five-year average NTM EV/S of 3.8x and within one standard deviation of the five-year average. This compares to a 60% premium and over two standard deviations above the five-year average on 2/18/14.
    This is consistent with our other med tech stock groups. While a 20% premium to the five-year average is sizable, it is consistent with the other med tech stock groups. The la

    Sentiment: Buy

MDXG
7.03+0.75(+11.94%)Jul 29 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
El Pollo Loco Holdings, Inc.
NasdaqGSTue, Jul 29, 2014 4:00 PM EDT
Buffalo Wild Wings Inc.
NasdaqGSTue, Jul 29, 2014 4:00 PM EDT